DJIA 16,974.68 14.11 0.08%
NASDAQ 4,447.58 -1.99 -0.04%
S&P 500 1,977.93 -0.41 -0.02%
market minute promo

301.71 -1.38 (-0.46%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $301.71 -0.46%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $302.25
Previous Close $303.09
Daily Range $299.73 - $303.62
52-Week Range $227.64 - $352.49
Market Cap $30.4B
P/E Ratio 86.85
Dividend (Yield) $0.00 (0.0%)
Volume 413,846
Average Daily Volume 968,564
Current FY EPS $9.29

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Cholesterol-Lowering Drug Market Heats Up

This video discusses Amgen's evolocumab, Rengeneron Pharmaceuticals and Sanofi's alirocumab, and the rest of the PCSK9 inhibitors.

Regeneron Pharmaceuticals Inc Stock Upgraded (REGN)

REGN, ILMN And CELG, Pushing Health Care Sector Downward

Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog

3 Stocks Reiterated As A Hold: NTAP, FSLR, REGN

InsiderInsights.com Daily Round Up: 7/17/14

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

Sector Update: Health Care Shares Mixed Pre-Market

Sector Update: Health Care

Notable Two Hundred Day Moving Average Cross - REGN

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Anal

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog

See More REGN News...

REGN's Top Competitors

REGN $301.71 (-0.46%)
Current stock: REGN
AMGN $122.67 (-0.14%)
Current stock: AMGN
GILD $91.60 (1.96%)
Current stock: GILD
BIIB $337.00 (0.46%)
Current stock: BIIB